| Purity (HPLC) | ≥99% HPLC (per component) |
|---|---|
| CAS Number | 863288-34-0 / 170851-70-4 |
| Molecular Formula | Blend |
| Molecular Weight | CJC-1295 3367.9 + Ipamorelin 711.9 g/mol |
| Sequence | CJC-1295 (mod. GRF 1-29) + Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) |
| Form | Lyophilized |
| Storage | Store dry at −20°C; 2–8°C after reconstitution |

CJC-1295 + Ipamorelin (5 + 5 mg)
32.46€
plus shipping
GHRH analog + GH secretagogue blend. Lyophilized, ≥99% HPLC. COA available.
- Purity
- ≥99% HPLC (per component)
- CAS
- 863288-34-0 / 170851-70-4
- Formula
- Blend
- Mol. weight
- CJC-1295 3367.9 + Ipamorelin 711.9 g/mol
- Form
- Lyophilized
- Storage
- Store dry at −20°C; 2–8°C after reconstitution
100 in stock
Certificate of Analysis
Every batch is independently tested by HPLC (purity), LC-MS (identity) and screened for endotoxins and heavy metals.
COA for this batch available on request.
Overview
This blend pairs CJC-1295 (a modified GHRH/GRF(1-29) analog) with Ipamorelin (a selective GH secretagogue) in one lyophilized vial for in-vitro GH-axis research.
Research background
Preclinical literature has examined GHRH-analog and GH-secretagogue co-signaling on the somatotropic axis in laboratory models.
All statements describe published third-party in-vitro / preclinical research only. Products are supplied strictly for laboratory research use — not for human or veterinary use.

Reviews
There are no reviews yet.